Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Pincus

Showing results (81-90 of 202) with videos related to

Pageof 21
Sort By:
Bulletin of the NYU Hospital for Joint Diseases|December 25, 2012
Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical careTheodore Pincus, Yusuf Yazici, Isabel Castrejón
Best Practice & Research. Clinical Rheumatology|August 7, 2007
A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computersTheodore Pincus, Yusuf Yazici, Martin Bergman
Neuroimmunomodulation|September 18, 2014
Circadian use of glucocorticoids in rheumatoid arthritisMaurizio Cutolo, Alberto Sulli, Theodore Pincus
Rheumatic Diseases Clinics of North America|December 8, 2009
Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measureTheodore Pincus, Yusuf Yazici, Tuulikki Sokka
Arthritis and Rheumatism|April 9, 2005
Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteriaTheodore Pincus, Ingrid Amara, Gary G Koch
The Journal of Rheumatology|August 2, 2008
Hotel-based medicineTheodore Pincus, Yusuf Yazici, Martin J Bergman
The Journal of Rheumatology|December 5, 2006
Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trialsTheodore Pincus, Yusuf Yazici, Ronald van Vollenhoven
Neuroimmunomodulation|September 18, 2014
Special issue on glucocorticoid therapy in rheumatic diseases: introductionMaurizio Cutolo, George P Chrousos, Theodore Pincus
Clinical and Experimental Rheumatology|October 3, 2017
A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0-10 visual analogue scalesIsabel Castrejón, Jacquelin R Chua, Theodore Pincus
Annals of Internal Medicine|January 5, 2002
Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?Theodore Pincus, Tuulikki Sokka, C Michael Stein
Pageof 21

Showing results (81-90 of 202) with videos related to

Sort By:
Pageof 21
Bulletin of the NYU Hospital for Joint Diseases|December 25, 2012
Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical careTheodore Pincus, Yusuf Yazici, Isabel Castrejón
Best Practice & Research. Clinical Rheumatology|August 7, 2007
A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computersTheodore Pincus, Yusuf Yazici, Martin Bergman
Neuroimmunomodulation|September 18, 2014
Circadian use of glucocorticoids in rheumatoid arthritisMaurizio Cutolo, Alberto Sulli, Theodore Pincus
Rheumatic Diseases Clinics of North America|December 8, 2009
Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measureTheodore Pincus, Yusuf Yazici, Tuulikki Sokka
Arthritis and Rheumatism|April 9, 2005
Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteriaTheodore Pincus, Ingrid Amara, Gary G Koch
The Journal of Rheumatology|August 2, 2008
Hotel-based medicineTheodore Pincus, Yusuf Yazici, Martin J Bergman
The Journal of Rheumatology|December 5, 2006
Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trialsTheodore Pincus, Yusuf Yazici, Ronald van Vollenhoven
Neuroimmunomodulation|September 18, 2014
Special issue on glucocorticoid therapy in rheumatic diseases: introductionMaurizio Cutolo, George P Chrousos, Theodore Pincus
Clinical and Experimental Rheumatology|October 3, 2017
A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0-10 visual analogue scalesIsabel Castrejón, Jacquelin R Chua, Theodore Pincus
Annals of Internal Medicine|January 5, 2002
Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?Theodore Pincus, Tuulikki Sokka, C Michael Stein
Pageof 21